|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cocci A, Cito G, Romano A, Larganà G,
Vignolini G, Minervini A, Di Maida F, Campi R, Carini M, Mondaini N
and Russo GI: Radical prostatectomy and simultaneous penile
prosthesis implantation: A narrative review. Int J Impot Res.
32:274–280. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weiner AB, Nettey OS and Morgans AK:
Management of metastatic hormone-sensitive prostate cancer (mHSPC):
An evolving treatment paradigm. Curr Treat Options Oncol. 20:62019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, et al: EAU
guidelines on prostate cancer. Part II: Treatment of advanced,
relapsing, and castration-resistant prostate cancer. Eur Urol.
65:467–479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wülfing C, Bögemann M, Goebell PJ,
Hammerer P, Machtens S, Pfister D, Schwentner C, Steuber T, von
Amsberg G and Schostak M: Treatment situation in metastastic
Castration Naive Prostate Cancer (mCRPC) and the implications on
clinical routine. Urologe A. 58:1066–1072. 2019.(In German).
View Article : Google Scholar
|
|
6
|
Dailey AL: Metabolomic bioinformatic
analysis. Methods Mol Biol. 1606:341–352. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spring FA, Dalchau R, Daniels GL,
Mallinson G, Judson PA, Parsons SF, Fabre JW and Anstee DJ: The Ina
and Inb blood group antigens are located on a glycoprotein of
80,000 MW (the CDw44 glycoprotein) whose expression is influenced
by the In(Lu) gene. Immunology. 64:37–43. 1988.PubMed/NCBI
|
|
8
|
Prochazka L, Tesarik R and Turanek J:
Regulation of alternative splicing of CD44 in cancer. Cell Signal.
26:2234–2239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miletti-González KE, Murphy K, Kumaran MN,
Ravindranath AK, Wernyj RP, Kaur S, Miles GD, Lim E, Chan R,
Chekmareva M, et al: Identification of function for CD44
intracytoplasmic domain (CD44-ICD). J Biol Chem. 287:18995–19007.
2012. View Article : Google Scholar
|
|
10
|
Nagano O and Saya H: Mechanism and
biological significance of CD44 cleavage. Cancer Sci. 95:930–935.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tai S, Sun Y, Squires JM, Zhang H, Oh WK,
Liang CZ and Huang J: PC3 is a cell line characteristic of
prostatic small cell carcinoma. Prostate. 71:1668–1679. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Qian L, Lin J, Huang G, Hao N, Wei
X, Wang W and Liang J: CD44 regulates prostate cancer
proliferation, invasion and migration via PDK1 and PFKFB4.
Oncotarget. 8:65143–65151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41((Database Issue)):
D991–D995. 2013.PubMed/NCBI
|
|
14
|
Edgar R, Domrachev M and Lash AE: Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Varambally S, Yu J, Laxman B, Rhodes DR,
Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, et
al: Integrative genomic and proteomic analysis of prostate cancer
reveals signatures of metastatic progression. Cancer Cell.
8:393–406. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chandran UR, Ma C, Dhir R, Bisceglia M,
Lyons-Weiler M, Liang W, Michalopoulos G, Becich M and Monzon FA:
Gene expression profiles of prostate cancer reveal involvement of
multiple molecular pathways in the metastatic process. BMC Cancer.
7:642007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu YP, Landsittel D, Jing L, Nelson J, Ren
B, Liu L, McDonald C, Thomas R, Dhir R and Finkelstein S: Gene
expression alterations in prostate cancer predicting tumor
aggression and preceding development of malignancy. J Clin Oncol.
22:2790–2799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aryee MJ, Liu W, Engelmann JC, Nuhn P,
Gurel M, Haffner MC, Esopi D, Irizarry RA, Getzenberg RH, Nelson
WG, et al: DNA methylation alterations exhibit intraindividual
stability and interindividual heterogeneity in prostate cancer
metastases. Sci Transl Med. 5:169ra102013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article32004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
22
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar
|
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Albertson DG and Pinkel D: Genomic
microarrays in human genetic disease and cancer. Hum Mol Genet 12
Spec No. 2:R145–R152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hejmej A and Bilinska B: A role of
junction-mediated interactions in cells of the male reproductive
tract: Impact of prenatal, neonatal, and prepubertal exposure to
anti-androgens on adult reproduction. Histol Histopathol.
29:815–830. 2014.PubMed/NCBI
|
|
28
|
Hejmej A and Bilinska B: The effects of
flutamide on cell-cell junctions in the testis, epididymis, and
prostate. Reprod Toxicol. 81:1–16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu CC, Chen LC, Lin VC, Huang CY, Cheng
WC, Hsieh AR, Chang TY, Lu TL, Lee CH, Huang SP and Bao BY: Effect
of genetic variants in cell adhesion pathways on the biochemical
recurrence in prostate cancer patients with radical prostatectomy.
Cancer Med. 8:2777–2783. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saucedo LJ and Edgar BA: Filling out the
Hippo pathway. Nat Rev Mol Cell Biol. 8:613–621. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thorne RF, Legg JW and Isacke CM: The role
of the CD44 transmembrane and cytoplasmic domains in co-ordinating
adhesive and signalling events. J Cell Sci. 117:373–380. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tannock IF, de Wit R, Berry WR, Horti J,
Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, et
al: Docetaxel plus prednisone or mitoxantrone plus prednisone for
advanced prostate cancer. N Engl J Med. 351:1502–1512. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takeuchi H, Mmeje CO, Jinesh GG, Taoka R
and Kamat AM: Sequential gemcitabine and tamoxifen treatment
enhances apoptosis and blocks transformation in bladder cancer
cells. Oncol Rep. 34:2738–2744. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan Y, Zuo X and Wei D: Concise review:
Emerging role of CD44 in cancer stem cells: A promising biomarker
and therapeutic target. Stem Cells Transl Med. 4:1033–1043. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rao G, Wang H, Li B, Huang L, Xue D, Wang
X, Jin H, Wang J, Zhu Y, Lu Y, et al: Reciprocal interactions
between tumor-associated macrophages and CD44-positive cancer cells
via Osteopontin/CD44 promote tumorigenicity in colorectal cancer.
Clin Cancer Res. 19:785–797. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takeuchi H, Tanaka M, Tanaka A, Tsunemi A
and Yamamoto H: Predominance of M2-polarized macrophages in bladder
cancer affects angiogenesis, tumor grade and invasiveness. Oncol
Lett. 11:3403–3408. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li W, Cohen A, Sun Y, Squires J, Braas D,
Graeber TG, Du L, Li G, Li Z, Xu X, et al: The role of CD44 in
glucose metabolism in prostatic small cell neuroendocrine
carcinoma. Mol Cancer Res. 14:344–353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takeuchi H, Taoka R, Mmeje CO, Jinesh GG,
Safe S and Kamat AM: CDODA-Me decreases specificity protein
transcription factors and induces apoptosis in bladder cancer cells
through induction of reactive oxygen species. Urol Oncol.
34:337.e11–e18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Harada H, Andersen JS, Mann M, Terada N
and Korsmeyer SJ: p70S6 kinase signals cell survival as well as
growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad
Sci USA. 98:9666–9670. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chu EC and Tarnawski AS: PTEN regulatory
functions in tumor suppression and cell biology. Med Sci Monit.
10:RA235–RA241. 2004.PubMed/NCBI
|
|
42
|
Glotzer M: Cytokinesis: Centralspindlin
moonlights as a membrane anchor. Curr Biol. 23:R145–R147. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiang W, Jimenez G, Wells NJ, Hope TJ,
Wahl GM, Hunter T and Fukunaga R: PRC1: A human mitotic
spindle-associated CDK substrate protein required for cytokinesis.
Mol Cell. 2:877–885. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gaudet S, Branton D and Lue RA:
Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl
Acad Sci USA. 97:5167–5172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Testa JR, Zhou JY, Bell DW and Yen TJ:
Chromosomal localization of the genes encoding the kinetochore
proteins CENPE and CENPF to human chromosomes 4q24->q25 and
1q32->q41, respectively, by fluorescence in situ hybridization.
Genomics. 23:691–693. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nabetani A, Koujin T, Tsutsumi C,
Haraguchi T and Hiraoka Y: A conserved protein, Nuf2, is implicated
in connecting the centromere to the spindle during chromosome
segregation: A link between the kinetochore function and the
spindle checkpoint. Chromosoma. 110:322–334. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Holland AJ and Cleveland DW: Losing
balance: The origin and impact of aneuploidy in cancer. EMBO Rep.
13:501–514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Johansson H and Simonsson S: Core
transcription factors, Oct4, Sox2 and Nanog, individually form
complexes with nucleophosmin (Npm1) to control embryonic stem (ES)
cell fate determination. Aging (Albany NY). 2:815–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mudbhary R, Hoshida Y, Chernyavskaya Y,
Jacob V, Villanueva A, Fiel MI, Chen X, Kojima K, Thung S, Bronson
RT, et al: UHRF1 overexpression drives DNA hypomethylation and
hepatocellular carcinoma. Cancer Cell. 25:196–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
